Literature DB >> 2982062

An enzymatic method for the consistent production of monodispersed viable cell suspensions from human solid tumors.

G H Rong, E A Grimm, W F Sindelar.   

Abstract

An enzymatic method is described for disaggregation of viable tumor cells from human solid tumors. The enzymatic cocktail consists of 0.1% collagenase, 0.01% hyaluronidase, and 0.002% deoxyribonuclease. After mechanical mincing of the tumor tissue, tumor specimens are dissociated by incubation in the enzymatic cocktail for 12-18 hours at room temperature. In 17 cases of sarcoma, the mean yield was 5 X 10(6) viable cells per gram tumor tissue. Yield was 1 X 10(7) viable cells per gram tumor tissue in 23 cases of gastrointestinal carcinoma. The viabilities of tumor cell suspensions ranged from 50 to 98%, except for low viabilities in four specimens that were grossly composed almost entirely of necrotic tissue. The dissociation procedure is simple and the viable cell yield is sufficient for applications in studies of human cancer immunobiology.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982062     DOI: 10.1002/jso.2930280213

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells.

Authors:  J J Mulé; S L Schwarz; A B Roberts; M B Sporn; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

2.  An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells.

Authors:  Jon G Quatromoni; Sunil Singhal; Pratik Bhojnagarwala; Wayne W Hancock; Steven M Albelda; Evgeniy Eruslanov
Journal:  J Leukoc Biol       Date:  2014-10-30       Impact factor: 4.962

3.  Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts.

Authors:  Wei Wei; Song Wu; Xiaolin Wang; Chris Kin-Wai Sun; Xiaoyang Yang; Xinrui Yan; Mei-Sze Chua; Samuel So
Journal:  Oncotarget       Date:  2014-07-30

4.  Active specific chemoimmunotherapy of lymph-node metastasis from a poorly immunogenic murine fibrosarcoma.

Authors:  K Naito; T Oka; S Nomi; H Yamagishi; B D Kahan
Journal:  Jpn J Cancer Res       Date:  1989-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.